Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 8Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Zollinger-Ellison Syndrome 1Stomach Ulcer 1Solid Tumours 1Solid Tumor 1Prostate Cancer Patients 1Pharmacokinetics of MDV3100 1Ovarian Neoplasms 1Mouth Neoplasms 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Inflammation 1Hyperuricemia 1Healthy Adult Participants 1Gout 1Esophagitis, Peptic 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Medullary 1Arthritis 1Advanced Solid Tumours 1Advanced Solid Tumors 1Advanced Solid Tumor 1

Interventions

enzalutamide 1Warfarin 1Pioglitazone 1Omeprazole 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pharmacokinetics of MDV3100 × Omeprazole × Clear all
NCT01911728 2017-06-26

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

Astellas Pharma Inc

Phase 1 Completed
14 enrolled
Genitourinary

Pharmacokinetics of MDV3100

Data powered by HemOnc (CC BY 4.0) Colophon âš¡